Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

Detalles Bibliográficos
Autores principales: Bowyer, Samantha, Prithviraj, Prashanth, Lorigan, Paul, Larkin, James, McArthur, Grant, Atkinson, Victoria, Millward, Michael, Khou, Muoi, Diem, Stefan, Ramanujam, Sangeetha, Kong, Ben, Liniker, Elizabeth, Guminski, Alexander, Parente, Phillip, Andrews, Miles C, Parakh, Sagun, Cebon, Jonathan, Long, Georgina V, Carlino, Matteo S, Klein, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396114/
https://www.ncbi.nlm.nih.gov/pubmed/28324885
http://dx.doi.org/10.1038/bjc.2017.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396114/
https://www.ncbi.nlm.nih.gov/pubmed/28324885
http://dx.doi.org/10.1038/bjc.2017.59

Ejemplares similares